Vatelizumab
Product Specifications
CAS Number
1238217-55-4
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Purity
0.9954
Bioactivity
Vatelizumab is a humanised monoclonal antibody targeting Integrin ?2?1 (very late antigen 2, VLA-2, CD49b), which enhances the frequency of regulatory T cells via the p38 MAPK signalling pathway and can be used for research into multiple sclerosis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1428672-01 0.02 mg (E-Coli)
Recombinant Lactobacillus plantarum 10 kDa chaperonin (groS)
Ask
View Details 
MBS1428672-02 0.1 mg (E-Coli)
Recombinant Lactobacillus plantarum 10 kDa chaperonin (groS)
Ask
View Details MBS1428672-03 0.02 mg (Yeast)
Recombinant Lactobacillus plantarum 10 kDa chaperonin (groS)
Ask
View Details 
MBS1428672-04 0.1 mg (Yeast)
Recombinant Lactobacillus plantarum 10 kDa chaperonin (groS)
Ask
View Details 
MBS1428672-05 0.02 mg (Baculovirus)
Recombinant Lactobacillus plantarum 10 kDa chaperonin (groS)
Ask
View Details MBS1428672-06 1 mg (E-Coli)
Recombinant Lactobacillus plantarum 10 kDa chaperonin (groS)
Ask
View Details